Dual inhibition of sodium–glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction

被引：0
|
作者：
Kim A. Connelly
Yanling Zhang
Jean-François Desjardins
Kerri Thai
Richard E. Gilbert
机构：
[1] St. Michael’s Hospital,Keenan Research Centre, Li Ka Shing Knowledge Institute
来源：
Cardiovascular Diabetology | / 17卷
关键词：
Sodium–glucose linked cotransporter; Myocardial infarction; Systole; Diastole;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction
    Ni T.
    Huang X.
    Pan S.
    Lu Z.
    Oxidative Medicine and Cellular Longevity, 2021, 2021
  • [22] Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausible
    Richard E. Gilbert
    Kim A. Connelly
    Cardiovascular Diabetology, 18
  • [23] Ribonucleicacid interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction
    Martin, Tamara P.
    MacDonald, Eilidh A.
    Bradley, Ashley
    Watson, Holly
    Saxena, Priyanka
    Rog-Zielinska, Eva A.
    Raheem, Anmar
    Fisher, Simon
    Elbassioni, Ali Ali Mohamed
    Almuzaini, Ohood
    Booth, Catriona
    Campbell, Morna
    Riddell, Alexandra
    Herzyk, Pawel
    Blyth, Karen
    Nixon, Colin
    Zentilin, Lorena
    Berry, Colin
    Braun, Thomas
    Giacca, Mauro
    McBride, Martin W.
    Nicklin, Stuart A.
    Cameron, Ewan R.
    Loughrey, Christopher M.
    CARDIOVASCULAR RESEARCH, 2023, 119 (16) : 2663 - 2671
  • [24] A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction
    Zhang, Yuan
    Elsik, Maros
    Edgley, Amanda J.
    Cox, Alison J.
    Kompa, Andrew R.
    Wang, Bing
    Tan, Christina Yan Ru
    Khong, Fay L.
    Stapleton, David I.
    Zammit, Steven
    Williams, Spencer J.
    Gilbert, Richard E.
    Krum, Henry
    Kelly, Darren J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1174 - 1185
  • [25] Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction JACC Review Topic of the Week
    Udell, Jacob A.
    Jones, W. Schuyler
    Petrie, Mark C.
    Harrington, Josephine
    Anker, Stefan D.
    Bhatt, Deepak L.
    Hernandez, Adrian F.
    Butler, Javed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (20) : 2058 - 2068
  • [26] Cardiac Fibroblast SWELL1 Regulates Ventricular Remodeling and Dysfunction Following Myocardial Infarction.
    Chen, Xiyao
    Zhang, Fuyang
    Tao, Ling
    Ma, Xinliang
    Wang, Xiaoming
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C26 - C26
  • [27] Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction
    Zhang, Fuyang
    Xia, Yunlong
    Yan, Wenjuan
    Zhang, Haoqiang
    Zhou, Fen
    Zhao, Shihao
    Wang, Wei
    Zhu, Di
    Xin, Chao
    Lee, Yan
    Zhang, Ling
    He, Yuan
    Gao, Erhe
    Tao, Ling
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2016, 310 (02): : H250 - H261
  • [28] Reduction in the incidence of myocardial infarction with sodium-glucose linked cotransporter-2 inhibitors: evident and plausible
    Gilbert, Richard E.
    Connelly, Kim A.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [29] Sphingosine 1-phosphate signaling contributes to cardiac inflammation, remodeling and dysfunction following myocardial infarction
    Zhang Fuyang
    Yan Wenjun
    Xia Yunlong
    Wang Wei
    Tao Ling
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C53 - C53
  • [30] microRNA-21 inhibition prevents adverse cardiac remodeling and dysfunction following myocardial infarction, an effect driven by macrophages
    Fernandez, I. Duran
    Ramanujam, D. P.
    Beck, C.
    Vaccarello, P.
    Engelhardt, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S3 - S3
12345